vs
Church & Dwight（CHD）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
Church & Dwight的季度营收约是瑞思迈的1.2倍（$1.6B vs $1.4B），瑞思迈净利率更高（27.6% vs 8.7%，领先18.9%），瑞思迈同比增速更快（11.0% vs 3.9%），过去两年瑞思迈的营收复合增速更高（7.9% vs 4.6%）
Church & Dwight是美国知名消费品企业，成立于1847年，总部位于新泽西州尤因。公司主营个人护理、家居用品及特色产品，旗下拥有Arm & Hammer、Trojan、OxiClean等知名品牌，2022年全年营收达54亿美元。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CHD vs RMD — 直观对比
营收规模更大
CHD
是对方的1.2倍
$1.4B
营收增速更快
RMD
高出7.0%
3.9%
净利率更高
RMD
高出18.9%
8.7%
两年增速更快
RMD
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.4B |
| 净利润 | $143.5M | $392.6M |
| 毛利率 | 45.8% | 61.8% |
| 营业利润率 | 16.2% | 34.6% |
| 净利率 | 8.7% | 27.6% |
| 营收同比 | 3.9% | 11.0% |
| 净利润同比 | -24.2% | 13.9% |
| 每股收益（稀释后） | $0.60 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHDRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $1.6B | $1.4B | ||
| Q3 25 | $1.6B | $1.3B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.5B | $1.2B | ||
| Q2 24 | $1.5B | $1.2B |
净利润CHDRMD
| Q2 26 | — | $392.6M | ||
| Q4 25 | $143.5M | $392.6M | ||
| Q3 25 | $182.2M | $348.5M | ||
| Q2 25 | $191.0M | $379.7M | ||
| Q1 25 | $220.1M | $365.0M | ||
| Q4 24 | $189.2M | $344.6M | ||
| Q3 24 | $-75.1M | $311.4M | ||
| Q2 24 | $243.5M | $292.2M |
毛利率CHDRMD
| Q2 26 | — | 61.8% | ||
| Q4 25 | 45.8% | 61.8% | ||
| Q3 25 | 45.1% | 61.5% | ||
| Q2 25 | 43.0% | 60.8% | ||
| Q1 25 | 45.0% | 59.3% | ||
| Q4 24 | 44.7% | 58.6% | ||
| Q3 24 | 45.2% | 58.6% | ||
| Q2 24 | 47.1% | 58.5% |
营业利润率CHDRMD
| Q2 26 | — | 34.6% | ||
| Q4 25 | 16.2% | 34.6% | ||
| Q3 25 | 16.1% | 33.4% | ||
| Q2 25 | 17.4% | 33.7% | ||
| Q1 25 | 20.1% | 33.0% | ||
| Q4 24 | 16.2% | 32.5% | ||
| Q3 24 | -6.1% | 31.6% | ||
| Q2 24 | 22.3% | 31.2% |
净利率CHDRMD
| Q2 26 | — | 27.6% | ||
| Q4 25 | 8.7% | 27.6% | ||
| Q3 25 | 11.5% | 26.1% | ||
| Q2 25 | 12.7% | 28.2% | ||
| Q1 25 | 15.0% | 28.3% | ||
| Q4 24 | 12.0% | 26.9% | ||
| Q3 24 | -5.0% | 25.4% | ||
| Q2 24 | 16.1% | 23.9% |
每股收益（稀释后）CHDRMD
| Q2 26 | — | $2.68 | ||
| Q4 25 | $0.60 | $2.68 | ||
| Q3 25 | $0.75 | $2.37 | ||
| Q2 25 | $0.78 | $2.58 | ||
| Q1 25 | $0.89 | $2.48 | ||
| Q4 24 | $0.76 | $2.34 | ||
| Q3 24 | $-0.31 | $2.11 | ||
| Q2 24 | $0.99 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.0M | $1.4B |
| 总债务越低越好 | $2.2B | $663.8M |
| 股东权益账面价值 | $4.0B | $6.3B |
| 总资产 | $8.9B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.55× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资CHDRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $409.0M | $1.4B | ||
| Q3 25 | $305.3M | $1.4B | ||
| Q2 25 | $923.2M | $1.2B | ||
| Q1 25 | $1.1B | $932.7M | ||
| Q4 24 | $964.1M | $521.9M | ||
| Q3 24 | $752.1M | $426.4M | ||
| Q2 24 | $491.7M | $238.4M |
总债务CHDRMD
| Q2 26 | — | $663.8M | ||
| Q4 25 | $2.2B | $403.9M | ||
| Q3 25 | $2.2B | $408.7M | ||
| Q2 25 | $2.2B | $658.4M | ||
| Q1 25 | $2.2B | $663.1M | ||
| Q4 24 | $2.2B | $662.9M | ||
| Q3 24 | $2.2B | $667.6M | ||
| Q2 24 | $2.2B | $697.3M |
股东权益CHDRMD
| Q2 26 | — | $6.3B | ||
| Q4 25 | $4.0B | $6.3B | ||
| Q3 25 | $4.2B | $6.1B | ||
| Q2 25 | $4.4B | $6.0B | ||
| Q1 25 | $4.6B | $5.5B | ||
| Q4 24 | $4.4B | $5.3B | ||
| Q3 24 | $4.2B | $5.2B | ||
| Q2 24 | $4.3B | $4.9B |
总资产CHDRMD
| Q2 26 | — | $8.5B | ||
| Q4 25 | $8.9B | $8.5B | ||
| Q3 25 | $9.1B | $8.3B | ||
| Q2 25 | $8.8B | $8.2B | ||
| Q1 25 | $9.0B | $7.6B | ||
| Q4 24 | $8.9B | $7.1B | ||
| Q3 24 | $8.7B | $7.2B | ||
| Q2 24 | $8.8B | $6.9B |
负债/权益比CHDRMD
| Q2 26 | — | 0.11× | ||
| Q4 25 | 0.55× | 0.06× | ||
| Q3 25 | 0.52× | 0.07× | ||
| Q2 25 | 0.50× | 0.11× | ||
| Q1 25 | 0.48× | 0.12× | ||
| Q4 24 | 0.51× | 0.13× | ||
| Q3 24 | 0.53× | 0.13× | ||
| Q2 24 | 0.51× | 0.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHD
| Household Products | $645.3M | 39% |
| Personal Care Products | $625.9M | 38% |
| Consumer International | $299.8M | 18% |
| Specialty Products Division | $73.2M | 4% |
RMD
暂无分部数据
